JNJ 8-K 2026-07-27

JOHNSON & JOHNSON (JNJ) 8-K dated 2026-07-27 — accession 0000200406-26-000155. This URL is the filing, not the JNJ hub.

JOHNSON & JOHNSON (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.

JOHNSON & JOHNSON filed a 8-K on 2026-07-27. Accession 0000200406-26-000155.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported JNJ revenue for 2025-12-28 was $94.19B. Net income was $26.80B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.

Not investment advice. The JNJ SEC hub lists recent forms. The stock page is the research view.